Pharmaceutical, Biotech and CROs

Discover Optimal Clinical Trials’ world-class recruitment and high-quality data for Phase 1b to 3 medical research trials in New Zealand.

Articles

The people to deliver – every day is valuable.

We are people on a mission. Our aim is to reduce suffering and help people around the world gain a better quality of life. We are dedicated to being one of the top research sites in Asia-Pacific.

“They have impressively fast start up times due to efficient yet robust ethics and regulatory systems.”

US Biotech

Optimal Clinical Trials is a private, independently owned, clinical research site in central Auckland – New Zealand’s largest city with a population of over 1.4 million people. Optimal has grown rapidly and is a Deloitte Fast 50 company and winner of multiple awards.

Provide Data

Report Results

Commission trial

Enroll & support

Participants

Optimal

CROs
& Sponsors


We specialise in conducting commercial phase 1b to 3 trials across a wide range of therapeutic areas, our team of expert investigators, doctors and research professionals make this possible.

We regularly work with the world’s largest pharmaceutical companies, Contract Research Organisations and many US biotechs. We are recognised for our speed, quality and responsiveness to clients’ needs.

Learn how to successfully run clinical trials in New Zealand

Don't have time to read the website? Download a copy of our "Successful Clinical Trials: How to accelerate your clinical program; get your first patient in quickly and meet your clinical trial milestones" guide.

Please tell us your first name

Please tell us your last name

Please tell us your company name

Please tell us your email

We specialise in a wide range of therapeutic areas

Better solutions for the worlds health
Analgesia

Analgesia

CRPS, Acute Pain, Chronic Pain

Anti-infectives

Anti-infectives

Vaccines, Antivirals

Cardiovascular

Cardiovascular

CAD, Hypertension, Hyperlipidaemia

CNS/Neurology

CNS/Neurology

Autism spectrum disorder, ADHD, Multiple Sclerosis, Parkinson’s Disease

Dermatology

Dermatology

Acne, Atopic Dermatitis, Psoriasis

ENT

ENT

Chronic Sinusitis

Endocrinology

Endocrinology

Diabetes (type 1 and 2), obesity, HRT, osteoporosis, paediatric metabolic

Gastroenterology

Gastroenterology

Coeliac disease

Infectious diseases

Infectious diseases

Influenza, RSV

Obstetrics & Gynaecology

Obstetrics & Gynaecology

Women’s health, Menopause

Orthopaedics

Orthopaedics

Respiratory & Allergy

Respiratory & Allergy

Asthma, COPD, Chronic Cough

Rheumatology

Rheumatology

Rheumatoid arthritis, giant cell arteritis

Plant & Natural

Plant & Natural

Cannabidiol, Honey

Paediatrics

Paediatrics

Vaccine, Autism Spectrum Disorder

Psychiatry

Psychiatry

Depression

Geriatric

Geriatric

Family medicine

Family medicine

General practice

Who We've Worked With In The Past


Sponsors

Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past

CROs

Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past
Who We've Worked With In The Past

Latest Key Stats

First Patient In

  • Global First patient in Neurology phase 1b study (Mar 19)
  • Global First patient in Immunology phase 3 study (April 19)
  • Global First patient in Paediatric phase 1b study (April 19)
  • New Zealand First patient in Dermatology phase 2a study (April 19)

Highest recruiting site

  • Global Immunology phase 3 study (May 19)
  • Australasia Vaccine phase 3 study (April 19)
  • Australasia Metabolic phase 2a study (Jul 18)